Esophageal cancer patients who underwent endoscopic submucosal dissection (ESD) for T1B tumors showed high en-bloc (100%) and R0 (82.3%) resection rates. Only 23.5% experienced tumor recurrence post-ESD, with safer outcomes in patients receiving additional therapies. Larger studies are necessary to confirm the long-term efficacy of ESD in T1B esophageal cancer.
Journal Article by Youssef M, Hanna C, Motomura D and Bechara R in Surg Endosc
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.